Repligen
RGEN
#2397
Rank
$7.95 B
Marketcap
$141.01
Share price
-1.80%
Change (1 day)
20.45%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): $78.05 Million USD

According to Repligen 's latest financial reports the company's current earnings are $0.76 Billion USD. In 2025 the company made an earning of $83.89 Million USD, an increase over its 2024 earnings that were of -$6.31 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $78.05 M-6.96%
2025 $83.89 M-1430.84%
2024 -$6.31 Million-113.01%
2023 $48.45 M-78.01%
2022 $0.22 B33.37%
2021 $0.16 B131.52%
2020 $71.35 M101.31%
2019 $35.44 M25.93%
2018 $28.14 M105.61%
2017 $13.68 M-11.46%
2016 $15.46 M14.91%
2015 $13.45 M20.26%
2014 $11.18 M-51.49%
2013 $23.06 M90.98%
2012 $12.07 M
2010 $0.17 M-103.81%
2009 -$4.59 Million-223.84%
2008 $3.7 M
2006 -$2.49 Million229.64%
2005 -$0.76 Million-89.16%
2004 -$6.97 Million-16.86%
2003 -$8.38 Million88.72%
2002 -$4.44 Million-27.88%
2001 -$6.16 Million-1.74%
2000 -$6.27 Million85.93%
1999 -$3.37 Million159.16%
1998 -$1.3 Million85.71%
1997 -$0.7 Million-70.83%
1996 -$2.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.59 B 13,468.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$7.42 B 9,408.92%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$11.45 B 14,569.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$9.59 B 12,195.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-$0.12 Billion-241.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-$64.46 Million-182.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$0.79 B 923.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$0.15 B 100.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38 B 394.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-$0.17 Billion-311.94%๐Ÿ‡บ๐Ÿ‡ธ USA